Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Endocrinology
|
December 1, 1995
Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis
A Sahu, M G Dube, C P Phelps, et al.
Regulatory Peptides
|
January 16, 1996
Differential increase in neuropeptide Y-like levels and myenteric neuronal staining in diabetic rat intestine
E Y Eaker, J E Sallustio, S D Marchand, et al.
The Journal of Surgical Research
|
June 1, 1995
Vasoactive intestinal peptide and substance P receptor antagonists improve postoperative ileus
N J Espat, G Cheng, M C Kelley, et al.
Endocrinology
|
December 1, 1992
Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats
A Sahu, C A Sninsky, C P Phelps, et al.
Transplantation
|
September 1, 1993
Assessment of proteinuria and neuropathy in the nonimmunosuppressed BB diabetic rat after abdominal intratesticular islet transplantation
F T Murray, A Beyer-Mears, R D Johnson, et al.
The American Journal of Physiology
|
January 1, 1983
Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine
C A Sninsky, M M Wolfe, J L Martin, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Metabolically programmed polyamine analogue antidiarrheals
R J Bergeron, G W Yao, H Yao, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2002
Long-term response to subtotal colectomy in colonic inertia
G Nicholas Verne, M P Hocking, R H Davis, et al.
Annals of Internal Medicine
|
September 1, 1991
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study
C A Sninsky, D H Cort, F Shanahan, et al.
Gastroenterology
|
August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group
W J Sandborn, W J Tremaine, D C Wolf, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Endocrinology
|
December 1, 1995
Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis
A Sahu, M G Dube, C P Phelps, et al.
Regulatory Peptides
|
January 16, 1996
Differential increase in neuropeptide Y-like levels and myenteric neuronal staining in diabetic rat intestine
E Y Eaker, J E Sallustio, S D Marchand, et al.
The Journal of Surgical Research
|
June 1, 1995
Vasoactive intestinal peptide and substance P receptor antagonists improve postoperative ileus
N J Espat, G Cheng, M C Kelley, et al.
Endocrinology
|
December 1, 1992
Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats
A Sahu, C A Sninsky, C P Phelps, et al.
Transplantation
|
September 1, 1993
Assessment of proteinuria and neuropathy in the nonimmunosuppressed BB diabetic rat after abdominal intratesticular islet transplantation
F T Murray, A Beyer-Mears, R D Johnson, et al.
The American Journal of Physiology
|
January 1, 1983
Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine
C A Sninsky, M M Wolfe, J L Martin, et al.
Journal of Medicinal Chemistry
|
June 21, 1996
Metabolically programmed polyamine analogue antidiarrheals
R J Bergeron, G W Yao, H Yao, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2002
Long-term response to subtotal colectomy in colonic inertia
G Nicholas Verne, M P Hocking, R H Davis, et al.
Annals of Internal Medicine
|
September 1, 1991
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study
C A Sninsky, D H Cort, F Shanahan, et al.
Gastroenterology
|
August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group
W J Sandborn, W J Tremaine, D C Wolf, et al.
Page
of 6